Dyslipidemia
Clinical trials for Dyslipidemia explained in plain language.
Never miss a new study
Get alerted when new Dyslipidemia trials appear
Sign up with your email to follow new studies for Dyslipidemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diabetes snack break: golden rice cookies take on bad cholesterol
Disease control CompletedThis study tests whether a cookie made from Golden Rice and red betel leaf can improve cholesterol and triglyceride levels in adults with type 2 diabetes. Over 28 days, 102 participants will eat the cookies daily, and their blood fat levels will be measured before and after. The …
Matched conditions: DYSLIPIDEMIA
Sponsor: Hasanuddin University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Ear pellets and statins: a new combo for high cholesterol?
Disease control CompletedThis study tests whether adding ear acupressure (small pellets on specific ear points) to the standard cholesterol drug atorvastatin can lower blood fats and improve phlegm-dampness symptoms better than a sham ear treatment plus atorvastatin. Eighty adults with dyslipidemia and p…
Matched conditions: DYSLIPIDEMIA
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New pill aims to lower 'Bad' cholesterol: first human test begins
Disease control CompletedResearchers are testing a new oral drug called AZD0780 in healthy adults, some with high LDL cholesterol. The Phase 1 trial gives single and multiple rising doses to check safety, side effects, and how the body processes the drug. About 183 volunteers will take either AZD0780 or …
Matched conditions: DYSLIPIDEMIA
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Could a common cholesterol drug boost mood treatment?
Disease control CompletedThis study looks at whether taking two approved medicines together—escitalopram for depression and atorvastatin for high cholesterol—can improve both mood and blood fat levels in adults. Participants are adults diagnosed with both a depressive episode and mild-to-moderate dyslipi…
Matched conditions: DYSLIPIDEMIA
Sponsor: Hengshui City Seventh People's Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could vinegar and fasting fix prediabetes cholesterol?
Disease control CompletedThis study tests whether taking date cider vinegar daily, alone or combined with 5:2 intermittent fasting, can improve cholesterol and other metabolic measures in adults with prediabetes and mild to moderate high cholesterol or blood pressure. Participants are randomly assigned t…
Matched conditions: DYSLIPIDEMIA
Sponsor: University of Lahore • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New cholesterol drugs enter human testing for first time
Disease control CompletedThis early-stage trial tests two experimental drugs, UI111 and UIC202006, in healthy adult volunteers. The goal is to check the drugs' safety and how the body processes them after a single dose taken with food. The study uses a crossover design, meaning each participant receives …
Matched conditions: DYSLIPIDEMIA
Phase 1 • Sponsor: Korea United Pharm. Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
One-Stop health check: can integrated care tame HIV and heart disease together?
Disease control CompletedThis trial tests a package of services called TASKPEN, which combines HIV care with screening and treatment for high blood pressure, diabetes, and tobacco use. It involves over 5,700 adults living with HIV in Lusaka, Zambia. The goal is to see if this integrated approach helps mo…
Matched conditions: DYSLIPIDEMIA
Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Fatty acid bars show promise for metabolic syndrome
Disease control CompletedThis study tested whether bars made with polyunsaturated fatty acids could improve cholesterol and fat levels in people with metabolic syndrome. 60 adults aged 40-65 with high BMI and abnormal cholesterol took part. The goal was to see if these bars could help control dyslipidemi…
Matched conditions: DYSLIPIDEMIA
Sponsor: University of Lahore • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Watermelon rind bread shows promise for heart health
Disease control CompletedThis study looked at whether bread made from watermelon rind could improve heart health in 120 adults with mild to moderate heart issues. Participants were between 35 and 65 years old and had conditions like high blood pressure, unhealthy cholesterol levels, or pre-diabetes. The …
Matched conditions: DYSLIPIDEMIA
Sponsor: University of Lahore • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Experimental drug targets harmful blood fats in early trial
Disease control CompletedThis early-stage study tested an experimental drug called ALN-APOC3 in 32 adults with dyslipidemia (abnormal blood fat levels). The main goal was to check safety and how the drug affects fat levels in the blood. Participants were otherwise healthy and either not on statins or on …
Matched conditions: DYSLIPIDEMIA
Phase 1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Tuna nuggets show promise for heart health
Disease control CompletedThis study tested whether eating tuna-based nuggets for three months could improve health in 120 people with heart disease and related conditions like obesity and diabetes. The nuggets were given as a source of selenium. Results showed improvements in some markers of inflammation…
Matched conditions: DYSLIPIDEMIA
Sponsor: University of Lahore Hospital (ULH) • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New study tests two ways to improve health in black adults with obesity
Disease control CompletedThis pilot study tested two approaches to improve metabolic health in Black adults with stage 1 obesity and conditions like high blood pressure or prediabetes. Participants received either weight-focused or weight-neutral health coaching for 7 weeks. The goal was to see if a larg…
Matched conditions: DYSLIPIDEMIA
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New drug aims to tackle two key risks in kidney dialysis patients
Disease control CompletedThis Phase 3 trial tested MCI-196, a drug that binds phosphorus and lowers cholesterol, in 642 adults on dialysis with chronic kidney disease. Participants received either MCI-196 or a placebo for 12 weeks. The goal was to see if the drug could safely reduce both serum phosphorus…
Matched conditions: DYSLIPIDEMIA
Phase 3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Two cholesterol drugs better than one? new study investigates
Disease control CompletedThis completed trial looked at whether taking two cholesterol-lowering drugs (rosuvastatin and ezetimibe) is more effective and safer than taking just one (rosuvastatin) for people with heart disease. 66 adults with high cholesterol were randomly assigned to one of the two treatm…
Matched conditions: DYSLIPIDEMIA
Phase 2/3 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Cutting red meat from mediterranean diet may slash cholesterol
Disease control CompletedThis study tested whether a Mediterranean diet that removes red and processed meat can lower LDL cholesterol and other heart disease risk factors. 157 adults with high cholesterol were assigned to either the special diet or standard heart-health advice for 8 weeks. Researchers me…
Matched conditions: DYSLIPIDEMIA
Sponsor: Universidad de Granada • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can a daily supplement blend curb cravings and improve cholesterol?
Disease control CompletedThis study tested whether a daily combination of commercially available food supplements could help overweight adults over 45 feel fuller and improve their cholesterol and blood sugar levels. Eighty participants were split into two groups: one took the supplement mix for 12 weeks…
Matched conditions: DYSLIPIDEMIA
Sponsor: University of Alicante • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New combo drug aims to tackle high cholesterol in one daily pill
Disease control CompletedThis Phase 3 trial tested a new combination drug called Cipros 10 against the standard statin Crestor in 146 adults with dyslipidemia (high cholesterol and triglycerides). The goal was to see if Cipros 10 could lower triglyceride levels more effectively. Participants took one pil…
Matched conditions: DYSLIPIDEMIA
Phase 3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New Cholesterol-Lowering pill shows promise in Mid-Stage trial
Disease control CompletedThis study tested a new daily medication called AZD0780 in 428 adults with dyslipidemia (abnormal cholesterol levels). Participants took one of several doses of AZD0780 or a placebo for 12 weeks. The main goal was to see how much the drug lowered LDL (bad) cholesterol compared to…
Matched conditions: DYSLIPIDEMIA
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New cholesterol combo drug shows promise in early trial
Disease control CompletedThis early-stage study tested a new drug called AZD0780 in 81 healthy adults with high cholesterol. Participants received AZD0780 alongside other cholesterol-lowering medicines like ezetimibe, rosuvastatin, or bempedoic acid. The goal was to see how well the combination lowers LD…
Matched conditions: DYSLIPIDEMIA
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Community health workers lead push to cut heart disease in pasifika communities
Disease control CompletedThis study tested a 3-month lifestyle program, delivered by Pasifika community health workers, to help Native Hawaiians and Pacific Islanders with conditions like diabetes, high blood pressure, and obesity. The program included healthy eating and activity tips plus support for so…
Matched conditions: DYSLIPIDEMIA
Sponsor: University of Hawaii • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New combo pill aims to lower cholesterol in phase 3 trial
Disease control CompletedThis completed Phase 3 trial tested a combination of two drugs, JW0108 and C2407, in 145 adults with high cholesterol (dyslipidemia). The goal was to see if the combo lowers LDL ('bad') cholesterol more effectively and safely than placebo. Researchers measured changes in LDL leve…
Matched conditions: DYSLIPIDEMIA
Phase 3 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated Jun 26, 2026 13:22 UTC
-
Emergency room visit could be a turning point for metabolic health
Prevention CompletedThis pilot trial tests whether a multi-part program given to emergency department patients with metabolic syndrome can encourage more walking and healthier habits. Participants receive a Fitbit, watch a short educational video, get a written exercise prescription, receive text re…
Matched conditions: DYSLIPIDEMIA
Sponsor: Indiana University • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Vitamin B3 supplement put to the test against psoriasis inflammation
Symptom relief CompletedResearchers are testing whether nicotinamide riboside, a form of vitamin B3 sold as a supplement, can reduce immune system activation in people with mild to moderate psoriasis. The trial enrolls adults aged 18 to 80 who are not on biologic therapy. Participants take either the su…
Matched conditions: DYSLIPIDEMIA
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Smoking and diet may shape cholesterol in mexican adults
Knowledge-focused CompletedResearchers are studying how traditional and non-traditional heart risk factors relate to cholesterol levels in hospitalized Mexican adults. The study focuses on HDL cholesterol, often called good cholesterol, and how it behaves in people who smoke or have certain dietary habits.…
Matched conditions: DYSLIPIDEMIA
Sponsor: Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Healthy volunteers to test if two cholesterol meds are identical
Knowledge-focused CompletedThis study checks if a new version of a cholesterol-lowering drug (AJU-C715) works the same as the original (C715R) in 60 healthy adults aged 19-59. Participants take a single dose of each drug in random order and have blood tests to compare drug levels. The goal is to see if the…
Matched conditions: DYSLIPIDEMIA
Phase 1 • Sponsor: AJU Pharm Co., Ltd. • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Scientists probe fat particles to unlock heart disease secrets
Knowledge-focused CompletedThis study looked at how fat-carrying particles called lipoproteins work in healthy people and those with high cholesterol or other lipid disorders. Researchers injected tiny, safe amounts of radioactive lipoproteins to track them in the body. The goal was to better understand ho…
Matched conditions: DYSLIPIDEMIA
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Gene hunt for rare cholesterol problems
Knowledge-focused CompletedThis study aimed to find new gene changes that cause rare lipid disorders. Researchers used advanced genetic testing to look at many genes at once in 140 people and their relatives. The goal was to discover causes that older methods missed.
Matched conditions: DYSLIPIDEMIA
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
STREAM trial: should seniors ditch statins?
Knowledge-focused CompletedThis study looks at whether adults aged 70 and older with multiple chronic conditions (but no heart disease) can safely stop taking statins. Researchers are comparing those who continue statins to those who stop, tracking deaths and major heart events over 2-4 years. The goal is …
Matched conditions: DYSLIPIDEMIA
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Fake health news: study reveals how online lies harm chronic patients
Knowledge-focused CompletedThis study looks at how false or misleading health information found online affects the way people with chronic illnesses like diabetes and high blood pressure take their medications and make treatment decisions. Researchers will survey 300 adults who use social media at least on…
Matched conditions: DYSLIPIDEMIA
Sponsor: Alexandria University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
New cholesterol drug candidate tested in healthy volunteers
Knowledge-focused CompletedThis early-stage trial tests a new drug called AJU-C716 against a reference drug (C716R) in 41 healthy adults aged 19 to 55. The goal is to see how safe the drug is and how the body processes it. This study does not test if the drug works for high cholesterol—it only looks at saf…
Matched conditions: DYSLIPIDEMIA
Phase 1 • Sponsor: AJU Pharm Co., Ltd. • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Scientists probe hidden link between blood protein and heart disease
Knowledge-focused CompletedThis study looked at 99 people with high heart risk to understand how a protein called CETP affects plaque buildup in arteries. Researchers measured CETP activity, artery thickness, and calcium scores. The goal was to learn more about heart disease, not to test a new treatment.
Matched conditions: DYSLIPIDEMIA
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New drug HRS-5632 tested in healthy people for safety
Knowledge-focused CompletedThis early-stage study tested a single injection of HRS-5632 in 50 healthy adults to check its safety and how the body processes it. Participants were aged 18 to 55 and in good health. The study did not aim to treat any disease, only to gather initial safety information.
Matched conditions: DYSLIPIDEMIA
Phase 1 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Scientists investigate why high 'Bad' cholesterol harms heart repair cells
Knowledge-focused CompletedThis completed study examined blood samples from 40 adults to see if high levels of lipoprotein (a), a type of cholesterol, are linked to fewer or different blood vessel repair cells. Participants with high Lp(a) were compared to those with normal levels. The goal was to better u…
Matched conditions: DYSLIPIDEMIA
Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC